table of content
1 Study Coverage
1.1 Age Related Macular Degeneration Drugs Product Introduction
1.2 Global Age Related Macular Degeneration Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Age Related Macular Degeneration Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Age Related Macular Degeneration Drugs Sales in Volume for the Year 2017-2028
1.3 United States Age Related Macular Degeneration Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Age Related Macular Degeneration Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Age Related Macular Degeneration Drugs Sales in Volume for the Year 2017-2028
1.4 Age Related Macular Degeneration Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Age Related Macular Degeneration Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Age Related Macular Degeneration Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Age Related Macular Degeneration Drugs Market Dynamics
1.5.1 Age Related Macular Degeneration Drugs Industry Trends
1.5.2 Age Related Macular Degeneration Drugs Market Drivers
1.5.3 Age Related Macular Degeneration Drugs Market Challenges
1.5.4 Age Related Macular Degeneration Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Age Related Macular Degeneration Drugs Market Segment by Type
2.1.1 Lucentis
2.1.2 Eylea
2.1.3 Avastin
2.1.4 Squalamine
2.1.5 Conercept
2.1.6 Lampalizamab
2.1.7 Others
2.2 Global Age Related Macular Degeneration Drugs Market Size by Type
2.2.1 Global Age Related Macular Degeneration Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Age Related Macular Degeneration Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Age Related Macular Degeneration Drugs Market Size by Type
2.3.1 United States Age Related Macular Degeneration Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Age Related Macular Degeneration Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Age Related Macular Degeneration Drugs Market Segment by Application
3.1.1 50-60 Years Old
3.1.2 60-70 Years Old
3.1.3 Others
3.2 Global Age Related Macular Degeneration Drugs Market Size by Application
3.2.1 Global Age Related Macular Degeneration Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Age Related Macular Degeneration Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Age Related Macular Degeneration Drugs Market Size by Application
3.3.1 United States Age Related Macular Degeneration Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Age Related Macular Degeneration Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Age Related Macular Degeneration Drugs Competitor Landscape by Company
4.1 Global Age Related Macular Degeneration Drugs Market Size by Company
4.1.1 Top Global Age Related Macular Degeneration Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Age Related Macular Degeneration Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Age Related Macular Degeneration Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Age Related Macular Degeneration Drugs Price by Manufacturer (2017-2022)
4.2 Global Age Related Macular Degeneration Drugs Concentration Ratio (CR)
4.2.1 Age Related Macular Degeneration Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Age Related Macular Degeneration Drugs in 2021
4.2.3 Global Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Age Related Macular Degeneration Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Age Related Macular Degeneration Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Age Related Macular Degeneration Drugs Market Size by Company
4.5.1 Top Age Related Macular Degeneration Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Age Related Macular Degeneration Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Age Related Macular Degeneration Drugs Sales by Players (2020, 2021 & 2022)
5 Global Age Related Macular Degeneration Drugs Market Size by Region
5.1 Global Age Related Macular Degeneration Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Age Related Macular Degeneration Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Age Related Macular Degeneration Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Age Related Macular Degeneration Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Age Related Macular Degeneration Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Age Related Macular Degeneration Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Age Related Macular Degeneration Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Age Related Macular Degeneration Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Age Related Macular Degeneration Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Age Related Macular Degeneration Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Age Related Macular Degeneration Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Age Related Macular Degeneration Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Age Related Macular Degeneration Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Age Related Macular Degeneration Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Age Related Macular Degeneration Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Age Related Macular Degeneration Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Age Related Macular Degeneration Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis Age Related Macular Degeneration Drugs Products Offered
7.1.5 Novartis Recent Development
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporation Information
7.2.2 Bayer Healthcare Description and Business Overview
7.2.3 Bayer Healthcare Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bayer Healthcare Age Related Macular Degeneration Drugs Products Offered
7.2.5 Bayer Healthcare Recent Development
7.3 Roche
7.3.1 Roche Corporation Information
7.3.2 Roche Description and Business Overview
7.3.3 Roche Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Age Related Macular Degeneration Drugs Products Offered
7.3.5 Roche Recent Development
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Corporation Information
7.4.2 Neurotech Pharmaceuticals Description and Business Overview
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Products Offered
7.4.5 Neurotech Pharmaceuticals Recent Development
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporation Information
7.5.2 Regeneron Pharmaceuticals Description and Business Overview
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Products Offered
7.5.5 Regeneron Pharmaceuticals Recent Development
7.6 Allergan
7.6.1 Allergan Corporation Information
7.6.2 Allergan Description and Business Overview
7.6.3 Allergan Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Age Related Macular Degeneration Drugs Products Offered
7.6.5 Allergan Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Age Related Macular Degeneration Drugs Industry Chain Analysis
8.2 Age Related Macular Degeneration Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Age Related Macular Degeneration Drugs Distributors
8.3 Age Related Macular Degeneration Drugs Production Mode & Process
8.4 Age Related Macular Degeneration Drugs Sales and Marketing
8.4.1 Age Related Macular Degeneration Drugs Sales Channels
8.4.2 Age Related Macular Degeneration Drugs Distributors
8.5 Age Related Macular Degeneration Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
